870606P

POVPC

Avanti Research^™ - A Croda Brand 870606P, powder

• Synonym(e): 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₂₉H₅₆NO₉P
• CAS-Nummer: 121324-31-0
• Molekulargewicht: 593.73
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 1 mg (870606P-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 870606P
• Lipid-Typ: phosphoglycerides; phospholipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCC([H])=O)=O)COC(CCCCCCCCCCCCCCC)=O)=O
• InChI: 1S/C29H56NO9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-20-28(32)36-25-27(39-29(33)21-18-19-23-31)26-38-40(34,35)37-24-22-30(2,3)4/h23,27H,5-22,24-26H2,1-4H3/t27-/m1/s1
• InChIKey: RKIDALSACBQVTN-HHHXNRCGSA-N

Beschreibung

Allgemeine Beschreibung

1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC) is a derivative of oxidized Low density lipoprotein (oxLDL), a proinflammatory lipid present in atherosclerotic lesions.

Anwendung

1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC) has been used:

• to study its effects on endothelial function and vasodilation
• as a ligand for LRP6 in bone marrow mesenchymal stromal cells (MSCs)
• as a oxidized lipid to study if membrane status at different degrees of lipid peroxidation is involved in oxidative stress tolerance

Biochem./physiol. Wirkung

1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC) affects endothelial function by hindering activity of endothelial nitric oxide synthase and stimulating endothelial cell apoptosis. It is implicated in the development of atherosclerosis and it may be used as a potent therapeutic for atherosclerosis.

Verpackung

5 mL Clear Glass Sealed Ampule (870606P-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids